Iron Triangle Partners LP - Q2 2022 holdings

$771 Million is the total value of Iron Triangle Partners LP's 25 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 82.1% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRput$150,900,000400,000
+100.0%
19.57%
ABBV BuyABBVIE INC$53,606,000
+37.8%
350,000
+45.8%
6.95%
+50.2%
HUM NewHUMANA INC$46,807,000100,000
+100.0%
6.07%
RGEN NewREPLIGEN CORP$40,600,000250,000
+100.0%
5.26%
GH BuyGUARDANT HEALTH INC$39,960,000
-16.5%
990,568
+37.2%
5.18%
-8.9%
BSX NewBOSTON SCIENTIFIC CORP$37,270,0001,000,000
+100.0%
4.83%
DXCM BuyDEXCOM INC$37,265,000
+4.1%
500,000
+614.3%
4.83%
+13.4%
ACHC BuyACADIA HEALTHCARE COMPANY IN$37,197,000
+12.9%
550,000
+9.4%
4.82%
+23.1%
ICLR SellICON PLC$34,672,000
-46.7%
160,000
-40.2%
4.50%
-41.9%
NBIX NewNEUROCRINE BIOSCIENCES INC$34,118,000350,000
+100.0%
4.42%
HQY SellHEALTHEQUITY INC$29,807,000
-9.2%
485,541
-0.3%
3.86%
-1.0%
AZN BuyASTRAZENECA PLCsponsored adr$28,904,000
+14.7%
437,477
+15.1%
3.75%
+25.0%
BIO NewBIO RAD LABS INCcl a$28,688,00057,955
+100.0%
3.72%
LEGN NewLEGEND BIOTECH CORPsponsored ads$27,243,000495,329
+100.0%
3.53%
CNMD BuyCONMED CORP$24,898,000
+4.4%
260,000
+62.0%
3.23%
+13.9%
CI NewCIGNA CORP NEW$21,082,00080,000
+100.0%
2.73%
INSP NewINSPIRE MED SYS INC$20,813,000113,938
+100.0%
2.70%
ESTA NewESTABLISHMENT LABS HLDGS INC$17,674,000325,008
+100.0%
2.29%
MASS Buy908 DEVICES INC$17,502,000
+29.1%
850,000
+19.2%
2.27%
+40.8%
HZNP SellHORIZON THERAPEUTICS PUB L$11,964,000
-77.4%
150,000
-70.2%
1.55%
-75.4%
OHPAU  ORION ACQUISITION CORPunit 02/19/2026$9,805,000
-0.1%
999,5130.0%1.27%
+8.9%
SGRY SellSURGERY PARTNERS INC$7,756,000
-64.8%
268,176
-33.0%
1.01%
-61.6%
KPTI SellKARYOPHARM THERAPEUTICS INC$4,961,000
-66.3%
1,100,000
-45.0%
0.64%
-63.3%
SellSOMALOGIC INC$4,520,000
-68.2%
1,000,000
-43.5%
0.59%
-65.3%
STXS SellSTEREOTAXIS INC$3,140,000
-50.8%
1,706,688
-0.3%
0.41%
-46.4%
NVST ExitENVISTA HOLDINGS CORPORATION$0-300,000
-100.0%
-1.74%
SGEN ExitSEAGEN INC$0-130,000
-100.0%
-2.23%
GDRX ExitGOODRX HLDGS INC$0-1,089,677
-100.0%
-2.50%
ALGN ExitALIGN TECHNOLOGY INC$0-50,000
-100.0%
-2.59%
NSTG ExitNANOSTRING TECHNOLOGIES INC$0-722,395
-100.0%
-2.99%
ICUI ExitICU MED INC$0-136,313
-100.0%
-3.61%
MOH ExitMOLINA HEALTHCARE INC$0-100,000
-100.0%
-3.97%
UTHR ExitUNITED THERAPEUTICS CORP DEL$0-190,073
-100.0%
-4.06%
HOLX ExitHOLOGIC INC$0-480,000
-100.0%
-4.39%
ILMN ExitILLUMINA INC$0-110,000
-100.0%
-4.57%
NVRO ExitNEVRO CORP$0-562,833
-100.0%
-4.84%
CTLT ExitCATALENT INC$0-392,663
-100.0%
-5.18%
UNH ExitUNITEDHEALTH GROUP INC$0-90,014
-100.0%
-5.46%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB LTD12Q3 20229.0%
GUARDANT HEALTH INC12Q3 20226.1%
CHARLES RIV LABS INTL INC11Q1 20237.8%
SURGERY PARTNERS INC11Q2 20236.4%
ICON PLC10Q3 202311.7%
BOSTON SCIENTIFIC CORP10Q3 20238.9%
NEVRO CORP10Q1 20226.7%
DEXCOM INC10Q3 20237.7%
ABBVIE INC9Q3 20238.1%
ACADIA HEALTHCARE COMPANY IN9Q3 20237.9%

View Iron Triangle Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Iron Triangle Partners LP's complete filings history.

Compare quarters

Export Iron Triangle Partners LP's holdings